Literature DB >> 8401055

Diagnosis and treatment of systemic lupus erythematosus.

P J Venables1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8401055      PMCID： PMC1678962          DOI： 10.1136/bmj.307.6905.663

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  14 in total

Review 1.  Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes.

Authors:  C Marguerie; C C Bunn; H L Beynon; R M Bernstein; J M Hughes; A K So; M J Walport
Journal:  Q J Med       Date:  1990-10

Review 2.  Treatment. Corticosteroids and anti-inflammatory drugs.

Authors:  R P Kimberly
Journal:  Rheum Dis Clin North Am       Date:  1988-04       Impact factor: 2.670

Review 3.  Connective tissue diseases: advances in diagnosis and management.

Authors:  T J Vyse; M J Walport
Journal:  Br J Hosp Med       Date:  1993 Jul 14-Aug 17

4.  Pulse methylprednisolone therapy in diffuse proliferative lupus nephritis.

Authors:  K S Barron; D A Person; E J Brewer; M G Beale; A M Robson
Journal:  J Pediatr       Date:  1982-07       Impact factor: 4.406

5.  A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment.

Authors:  J C Edwards; M L Snaith; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

Review 6.  Treatment. Disease-modifying therapies.

Authors:  J D Lieberman; S Schatten
Journal:  Rheum Dis Clin North Am       Date:  1988-04       Impact factor: 2.670

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Fetal survival after prednisone suppression of maternal lupus-anticoagulant.

Authors:  W F Lubbe; W S Butler; S J Palmer; G C Liggins
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

9.  Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study.

Authors:  A J Silman; J Petrie; B Hazleman; S J Evans
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

Review 10.  Treatment of systemic lupus erythematosus.

Authors:  M L Miller
Journal:  Curr Opin Rheumatol       Date:  1992-10       Impact factor: 5.006
View more
  6 in total

Review 1.  Combination treatment in autoimmune diseases: systemic lupus erythematosus.

Authors:  G Moroni; O Della Casa Alberighi; C Ponticelli
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Diagnosis and management of systemic lupus erythematosus. Thalidomide modifies disease.

Authors:  N P Burrows
Journal:  BMJ       Date:  1993-10-09

3.  Diagnosis and management of systemic lupus erythematosus. Sun protection is vital.

Authors:  J Yell; F Wojnarowska
Journal:  BMJ       Date:  1993-10-09

Review 4.  IFN-gamma transgenic mice: clues to the pathogenesis of systemic lupus erythematosus?

Authors:  J P Seery
Journal:  Arthritis Res       Date:  2000-08-25

5.  Systemic Lupus Erythematosus in a 12-Year-Old Boy: A Rare Entity in Childhood.

Authors:  Shilpashree Hs
Journal:  Int J Clin Pediatr Dent       Date:  2010-09-15

6.  Time to Include Fine Specificity Anti-Citrullinated Protein Antibodies in the Routine Diagnosis and Management of Rheumatoid Arthritis?

Authors:  Anja Schwenzer; Anne-Marie Quirke; Anna B Montgomery; Patrick J Venables; Harlan R Sayles; Wolfgang Schlumberger; Jeffrey B Payne; Ted R Mikuls; Kim S Midwood
Journal:  Arthritis Rheumatol       Date:  2019-02-09       Impact factor: 10.995
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.